Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 17/20 | 0.41 |
| ▸ | MAOB | P27338 | 12/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15079849 | 0.88 | SMN1; SMN2 (0.42) | MAOBNPC1MAPTRAB9A | |
| SCHEMBL15079366 | 0.83 | KDM4E (0.44) | NPC1MAPTRAB9A | |
| SCHEMBL15079775 | 0.81 | MAPT (0.39) | NPC1MAPTRAB9A | |
| SCHEMBL15079895 | 0.77 | ATF4 (0.40) | NPC1MAPTRAB9A | |
| SCHEMBL15079880 | 0.77 | LTA4H (0.43) | HRH3MAOB | |
| SCHEMBL15079886 | 0.77 | LMNA (0.39) | HRH3NPC1MAPTRAB9A | |
| SCHEMBL15079856 | 0.77 | MEN1 (0.45) | MAOBMAPTRAB9A | |
| SCHEMBL15079756 | 0.77 | KMT2A (0.39) | NPC1MAPTRAB9A | |
| SCHEMBL15079779 | 0.75 | MAOB (0.44) | HRH3MAOBMAPT | |
| SCHEMBL15079771 | 0.74 | TDP1 (0.47) | HRH3NPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150004110-A1 | NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS | DIVERCHIM (FR) | 2015-01-01 | — | — | US | disclosed |
| US-20150004110-A1 | NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS | DIVERCHIM (FR) | 2015-01-01 | — | — | US | disclosed |
| WO-2013093320-A1 | NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS | DIVERCHIM (FR) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150004110-A1 | NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS | ARG1, TYR, NOS1 | HRH3 454/4885MAOB 484/4885NPC1 2259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.